SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001085146-23-000891
Filing Date
2023-02-09
Accepted
2023-02-09 16:01:18
Documents
1

Document Format Files

Seq Description Document Type Size
1 PRIMECAP MANAGEMENT CO/CA/ nktra13_20923.htm SC 13G/A 26364
  Complete submission text file 0001085146-23-000891.txt   28028
Mailing Address 177 EAST COLORADO BLVD. 11TH FLOOR PASADENA CA 91105
Business Address 177 EAST COLORADO BLVD. 11TH FLOOR PASADENA CA 91105 6263049222
PRIMECAP MANAGEMENT CO/CA/ (Filed by) CIK: 0000763212 (see all company filings)

IRS No.: 953868081
Type: SC 13G/A

Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Subject) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-45385 | Film No.: 23606086
SIC: 2834 Pharmaceutical Preparations